Dexamethasone sodium phosphate is a steroid medication used to reduce inflammation and suppress the immune system in conditions like severe allergies, autoimmune diseases, certain cancers, and to reduce brain swelling. It can also be used to prevent nausea from chemotherapy and to treat adrenal gland insufficiency.[1] Decadron is currently being investigated across 62 indications[3], with its most advanced program in Phase 3.[1]
Decadron is one of 706 small molecule programs targeting Systemic Lupus Erythematosus. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
375 competitors in Lymphoma
Decadron
Zofran
Cabenuva
Norvir
Emend
Kenalog
Nuvigil
Elitek
Solu-Medrol
Systemic Therapy
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details